One way the next generation of angel investors is acting more like VCs (and it’s actually a good thing)
"Traditionally we waited for folks to come to us."
Queen City Angels’ chairman testifies before Congress on angel investing
Queen City Angels’ Chairman Tony Shipley testified before a House subcommittee last week on the value angel investing brings to the U.S. economy. Shipley represented the Angel Capital Association in making his statement to the House Committee on Small Business Subcommittee on Economic Growth, Tax and Capital Access, according to a statement from Cincinnati-based Queen […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Stroke diagnosis company IschemiaCare planning clinical study
A startup that’s developing a blood test to diagnose the cause of stroke is planning a clinical study that could pave the way to commercial sales of the test. Cincinnati-based IschemiaCare plans to begin the study in the second half of this year, and the young company has attracted some big-name partners to help it […]
Queen City Angels aims for new $6M fund
Queen City Angels, a frequent investor in early stage healthcare startups, is hoping to raise a $6 million fund, its fourth. The Cincinnati-area angel group is hoping to obtain half of that amount through the state of Ohio’s Third Frontier technology support program, operations manager Jim Cunningham said. The roughly 50-member QCA has invested about […]
Stroke diagnosis firm IschemiaCare closes $800K of $1.1M investment
A company that’s hoping to be the first to commercialize a blood test that can diagnose the cause of stroke has closed $800,000 of an anticipated $1.1 million series B round of investment. Cincinnati-area-based IschemiaCare expects to close on the full $1.1 million by the end of the year. The funding will enable the company […]
Minimally Invasive Devices raises $1.5M, eyes new product launches
Surgical device maker Minimally Invasive Devices has raised more than $1.5 million in equity, according to a document filed with the Securities and Exchange Commission.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Ohio startup looks to commercialize blood test for stroke cause
Don't accuse molecular diagnostics startup Ischemia Care of thinking small. The Oxford, Ohio-based company that was founded three years ago is hoping to be the first company to market with a blood test to diagnose the cause of stroke, the fourth-leading cause of death in the United States. And it's hoping to do that within two years.
Blue Ash Therapeutics raises $2M-plus to push drug over finish line
Blue Ash Therapeutics has raised more than $2 million to help push its first and only drug across the regulatory finish line with a pivotal clinical trial. Started more than a year ago by pharmaceutical industry veterans Greg Flexter and Kevin Malloy, the Cincinnati company is finishing development of Azimilide, a drug that can work […]
Queen City Angels defy bad economy, invest in 8 health care companies
Queen City Angels invested in seven life sciences companies and one health information technology company last year, according to its 2009 annual operating report (pdf). The group of accredited investors finished the year with 12 investments, which included three IT companies and one company specializing in advanced materials. In addition, the angel group created a […]
Columbus venture group Ohio TechAngel Funds raises $2.5M for third fund
Early stage venture group Ohio TechAngel Funds has raised $2.5 million for its third investment fund. Like the group's previous funds, Ohio TechAngel Fund III will invest in Ohio-based technology companies in the life and physical sciences, and information technology industries.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
BIOSTART, Queen City Angels team up to recruit life sciences investors
BIOSTART and Queen City Angels have formalized their long-standing relationship through a challenge: Jointly recruit 10 life sciences investors for the angel group within two years.
Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors
Neuros Medical Inc., a start-up company that is developing a neurostimulation device to block chronic pain, has landed $1.8 million from several investors during its first round of venture financing. Neuros Medical will use the money to begin product development, hire a chief technology officer and complete clinical studies on its device that stimulates nerves to alleviate pain.
Entrepreneurs should have their credit cards ready
Tony Shipley of Queen City Angels says the old-school approach to starting a business is new again because of the dearth of private equity. Investors have become much more discerning -- even among the companies they've invested in. "People casually thinking about entrepreneurship must be really committed to operating effectively and efficiently or else they’re better off keeping their day job," Shipley said in an interview.
AssureRx hires new CEO, prepares for Series A fund-raise later this year
New chief executive James S. Burns is the former head of oncology and inflammatories drugmaker EntreMed. "This is a signal to our current and next investors that we're ready to make the next step," said Al Lucas, AssureRx's vice president of sales and marketing.